Related Experiment Video
Updated: Apr 26, 2026
09:31
Visualization of Amyloid β Deposits in the Human Brain with Matrix-assisted Laser Desorption/Ionization Imaging Mass Spectrometry
Published on: March 7, 2019
9.6K
[Cerebral amyloid angiopathy]
T A Makotrova1, O S Levin, A V Arablinskiĭ
1Kafedra nevrologii GOU DPO "Rossiĭskaia meditsinskaia akademiia postdiplomnogo obrazovaniia" Minzdrava Rossii, Moskva.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova
|July 22, 2014
Summary
Cerebral amyloid angiopathy (CAA), linked to Alzheimer's disease (AD), involves amyloid protein buildup in brain vessels. Understanding CAA is crucial for managing risks like brain hemorrhages during certain medical treatments.
Area of Science:
- Neurology
- Pathology
- Neuroimaging
Context:
- Cerebral amyloid angiopathy (CAA) is a cerebrovascular disorder involving beta-amyloid deposition in brain arteries.
- CAA often co-occurs with Alzheimer's disease (AD), complicating diagnosis and treatment.
- Understanding CAA's pathophysiology and clinical impact is essential for patient management.
Purpose:
- To provide an up-to-date review of Cerebral Amyloid Angiopathy (CAA).
- To discuss the pathophysiology, clinical manifestations, and diagnostic methods for CAA.
- To highlight the clinical significance of CAA, particularly concerning hemorrhage risks.
Summary:
- Cerebral amyloid angiopathy (CAA) is characterized by beta-amyloid protein deposition in cerebral small arteries and capillaries.
- This condition can be independent or associated with Alzheimer's disease (AD).
- Diagnosis involves neuroimaging and biomarkers, with cerebral microbleeds (CMBs) serving as potential markers for both AD and CAA.
Impact:
- CAA identification is critical for assessing intracerebral hemorrhage risk in patients undergoing thrombolytic or warfarin therapy.
- This knowledge aids in managing patients with acute myocardial infarction, pulmonary embolism, or ischemic stroke.
- Improved understanding of CAA pathophysiology and clinical significance can lead to better patient outcomes and safer therapeutic strategies.
Related Concept Videos
01:22Cerebral Edema ll: Pathophysiology
11
Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this...
11
01:22Dementia l: Introduction
29
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
29
01:17Hemorrhagic Stroke l: Introduction
16
A hemorrhagic stroke is an acute neurological event that occurs when a weakened cerebral blood vessel ruptures, allowing blood to accumulate within or around the brain. The sudden release of blood forms a focal hematoma that increases intracranial pressure, displaces neural tissue, and can obstruct cerebrospinal fluid pathways. These effects may be compounded by intraventricular extension of the hemorrhage, cerebral edema, or compression of adjacent structures, all of which contribute to...
16
01:23Alzheimer Disease ll: Pathophysiology
27
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and...
27
01:26Alzheimer's Disease: Overview
1.7K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.7K
01:19Cerebral Edema l: Introduction
18
Cerebral edema is a pathological increase in brain water content that disrupts intracranial pressure regulation and impairs neurological function. Because the cranial vault is rigid, even modest increases in tissue volume can compromise cerebral perfusion, distort neural structures, and initiate secondary injury. Cerebral edema develops through four principal mechanisms: vasogenic, cytotoxic, interstitial, and ionic.Vasogenic EdemaVasogenic edema arises from disruption of the blood–brain...
18